<VariationArchive VariationID="142253" VariationName="NM_005359.6(SMAD4):c.1245_1248del (p.Asp415Glufs)" VariationType="Deletion" Accession="VCV000142253" Version="53" RecordType="classified" NumberOfSubmissions="16" NumberOfSubmitters="15" DateLastUpdated="2024-07-29" DateCreated="2013-04-04" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="151967" VariationID="142253">
      <GeneList>
        <Gene Symbol="SMAD4" FullName="SMAD family member 4" GeneID="4089" HGNC_ID="HGNC:6770" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>18q21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="51030213" stop="51085042" display_start="51030213" display_stop="51085042" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="48556582" stop="48611411" display_start="48556582" display_stop="48611411" Strand="+" />
          </Location>
          <OMIM>600993</OMIM>
          <Haploinsufficiency last_evaluated="2020-12-16" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SMAD4">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-12-16" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SMAD4">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_005359.6(SMAD4):c.1245_1248del (p.Asp415Glufs)</Name>
      <CanonicalSPDI>NC_000018.10:51067120:AGACAGA:AGA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>18q21.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="51067121" stop="51067124" display_start="51067121" display_stop="51067124" variantLength="4" positionVCF="51067120" referenceAlleleVCF="TAGAC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="48593491" stop="48593494" display_start="48593491" display_stop="48593494" variantLength="4" positionVCF="48593490" referenceAlleleVCF="TAGAC" alternateAlleleVCF="T" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.10" sequenceAccession="NC_000018" sequenceVersion="10" change="g.51067124_51067127del" Assembly="GRCh38">
            <Expression>NC_000018.10:g.51067124_51067127del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.9" sequenceAccession="NC_000018" sequenceVersion="9" change="g.48593494_48593497del" Assembly="GRCh37">
            <Expression>NC_000018.9:g.48593494_48593497del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_013013.2" sequenceAccession="NG_013013" sequenceVersion="2" change="g.104085_104088del">
            <Expression>NG_013013.2:g.104085_104088del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005359.6" sequenceAccession="NM_005359" sequenceVersion="6" change="c.1245_1248del" MANESelect="true">
            <Expression>NM_005359.6:c.1245_1248del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005350.1" sequenceAccession="NP_005350" sequenceVersion="1" change="p.Asp415fs">
            <Expression>NP_005350.1:p.Asp415fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_318" sequenceAccession="LRG_318">
            <Expression>LRG_318:g.104085_104088del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_318t1" sequenceAccession="LRG_318t1">
            <Expression>LRG_318t1:c.1245_1248del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005359.5" sequenceAccession="NM_005359" sequenceVersion="5" change="c.1245_1248delCAGA">
            <Expression>NM_005359.5:c.1245_1248delCAGA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005359.5" sequenceAccession="NM_005359" sequenceVersion="5" change="c.1244_1247delACAG">
            <Expression>NM_005359.5:c.1244_1247delACAG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA259232" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="600993.0005" DB="OMIM" />
        <XRef Type="rs" ID="80338965" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005359.6(SMAD4):c.1245_1248del (p.Asp415Glufs) AND Hereditary cancer-predisposing syndrome" Accession="RCV000131266" Version="16">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-01-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005359.6(SMAD4):c.1245_1248del (p.Asp415Glufs) AND Generalized juvenile polyposis/juvenile polyposis coli" Accession="RCV000205495" Version="25">
        <ClassifiedConditionList TraitSetID="2255">
          <ClassifiedCondition DB="MedGen" ID="C1868081">Generalized juvenile polyposis/juvenile polyposis coli</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2020-02-05" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005359.6(SMAD4):c.1245_1248del (p.Asp415Glufs) AND not provided" Accession="RCV000254690" Version="21">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-09-20" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005359.6(SMAD4):c.1245_1248del (p.Asp415Glufs) AND multiple conditions" Accession="RCV000768095" Version="9">
        <ClassifiedConditionList TraitSetID="13676">
          <ClassifiedCondition DB="MedGen" ID="C0235974">Carcinoma of pancreas</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1868081">Generalized juvenile polyposis/juvenile polyposis coli</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1832942">Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0796081">Myhre syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-09-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005359.6(SMAD4):c.1245_1248del (p.Asp415Glufs) AND Carcinoma of colon" Accession="RCV001357425" Version="10">
        <ClassifiedConditionList TraitSetID="1735">
          <ClassifiedCondition DB="MedGen" ID="C0699790">Carcinoma of colon</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005359.6(SMAD4):c.1245_1248del (p.Asp415Glufs) AND Juvenile polyposis syndrome" Accession="RCV001376606" Version="13">
        <ClassifiedConditionList TraitSetID="65684">
          <ClassifiedCondition DB="MedGen" ID="C0345893">Juvenile polyposis syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-20" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005359.6(SMAD4):c.1245_1248del (p.Asp415Glufs) AND multiple conditions" Accession="RCV002311019" Version="9">
        <ClassifiedConditionList TraitSetID="81098">
          <ClassifiedCondition DB="MedGen" ID="C4707243">Familial thoracic aortic aneurysm and aortic dissection</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-07-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005359.6(SMAD4):c.1245_1248del (p.Asp415Glufs) AND multiple conditions" Accession="RCV003227672" Version="8">
        <ClassifiedConditionList TraitSetID="74620">
          <ClassifiedCondition DB="MedGen" ID="C0235974">Carcinoma of pancreas</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0345893">Juvenile polyposis syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1832942">Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0796081">Myhre syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-03-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005359.6(SMAD4):c.1245_1248del (p.Asp415Glufs) AND Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome" Accession="RCV003485541" Version="2">
        <ClassifiedConditionList TraitSetID="2354">
          <ClassifiedCondition DB="MedGen" ID="C1832942">Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-02-09" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-09" NumberOfSubmissions="16" NumberOfSubmitters="15" DateCreated="2013-04-04" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10398437</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11920286</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15235019</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16152648</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16436638</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17873119</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18355998</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18823382</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22316667</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22748914</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22810475</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23239472</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23399955</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26681312</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27375208</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28944238</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33097490</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">35943490</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9582123</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301642</ID>
          <ID Source="BookShelf">NBK1469</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="13676" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2251" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Growth mental deficiency syndrome of Myhre</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Myhre syndrome</ElementValue>
                <XRef ID="Growth+Mental+Deficiency+Syndrome+of+Myhre/3195" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007688" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LARYNGOTRACHEAL STENOSIS, ARTHROPATHY, PROGNATHISM, AND SHORT STATURE</ElementValue>
                <XRef Type="MIM" ID="139210" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LAPS SYNDROME</ElementValue>
                <XRef Type="MIM" ID="139210" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MYHRS</ElementValue>
                <XRef Type="MIM" ID="139210" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Myhre syndrome is a connective tissue disorder with multisystem involvement, progressive and proliferative fibrosis that may occur spontaneously or following trauma or surgery, mild-to-moderate intellectual disability, and in some instances, autistic-like behaviors. Organ systems primarily involved include: cardiovascular (congenital heart defects, long- and short-segment stenosis of the aorta and peripheral arteries, pericardial effusion, constrictive pericarditis, restrictive cardiomyopathy, and hypertension); respiratory (choanal stenosis, laryngotracheal narrowing, obstructive airway disease, or restrictive pulmonary disease), gastrointestinal (pyloric stenosis, duodenal strictures, severe constipation); and skin (thickened particularly on the hands and extensor surfaces). Additional findings include distinctive craniofacial features and skeletal involvement (intrauterine growth restriction, short stature, limited joint range of motion). To date, 55 individuals with molecularly confirmed Myhre syndrome have been reported.</Attribute>
                <XRef ID="NBK425723" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2572" />
                <XRef ID="2572" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">28406602</ID>
                <ID Source="BookShelf">NBK425723</ID>
              </Citation>
              <XRef ID="2588" DB="Orphanet" />
              <XRef ID="C0796081" DB="MedGen" />
              <XRef ID="MONDO:0007688" DB="MONDO" />
              <XRef Type="MIM" ID="139210" DB="OMIM" />
            </Trait>
            <Trait ID="2501" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Juvenile polyposis coli</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Generalized juvenile polyposis/juvenile polyposis coli</ElementValue>
                <XRef ID="MONDO:0008276" DB="MONDO" />
                <XRef ID="329971" DB="Orphanet" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Juvenile polyposis syndrome (JPS) is characterized by predisposition to hamartomatous polyps in the gastrointestinal (GI) tract, specifically in the stomach, small intestine, colon, and rectum. The term "juvenile" refers to the type of polyp rather than to the age of onset of polyps. Most individuals with JPS have some polyps by age 20 years; some may have only four or five polyps over their lifetime, whereas others in the same family may have more than 100. If the polyps are left untreated, they may cause bleeding and anemia. Most juvenile polyps are benign; however, malignant transformation can occur. Risk for GI cancers ranges from 11% to 86%. Most of this increased risk is attributed to colon cancer, but cancers of the stomach, upper GI tract, and pancreas have also been reported. A combined syndrome of JPS and hereditary hemorrhagic telangiectasia (HHT) is present in most individuals with an SMAD4 pathogenic variant.</Attribute>
                <XRef ID="NBK1469" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17508" />
                <XRef ID="17508" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301642</ID>
                <ID Source="BookShelf">NBK1469</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2004">
                <ID Source="PubMed">15604628</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACG, 2015">
                <ID Source="PubMed">25645574</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Genetics of Colorectal Cancer">
                <ID Source="PubMed">26389505</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <XRef ID="329971" DB="Orphanet" />
              <XRef ID="C1868081" DB="MedGen" />
              <XRef ID="MONDO:0008276" DB="MONDO" />
            </Trait>
            <Trait ID="2502" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">JP/HHT SYNDROME</ElementValue>
                <XRef Type="MIM" ID="175050" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">JUVENILE POLYPOSIS WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA</ElementValue>
                <XRef Type="MIM" ID="175050" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">POLYPOSIS, GENERALIZED JUVENILE, WITH PULMONARY ARTERIOVENOUS MALFORMATION</ElementValue>
                <XRef Type="MIM" ID="175050" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">TELANGIECTASIA, HEREDITARY HEMORRHAGIC, WITH JUVENILE POLYPOSIS COLI</ElementValue>
                <XRef Type="MIM" ID="175050" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome</ElementValue>
                <XRef ID="Juvenile+polyposis-hereditary+hemorrhagic+telangiectasia+syndrome/8700" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008278" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">JPHT</ElementValue>
                <XRef Type="MIM" ID="175050" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">JPS/HHT</ElementValue>
                <XRef Type="MIM" ID="175050" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">JP/HHT</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hereditary hemorrhagic telangiectasia (HHT) is characterized by the presence of multiple arteriovenous malformations (AVMs) that lack intervening capillaries and result in direct connections between arteries and veins. The most common clinical manifestation is spontaneous and recurrent nosebleeds (epistaxis) beginning on average at age 12 years. Telangiectases (small AVMs) are characteristically found on the lips, tongue, buccal and gastrointestinal (GI) mucosa, face, and fingers. The appearance of telangiectases is generally later than epistaxis but may be during childhood. Large AVMs occur most often in the lungs, liver, or brain; complications from bleeding or shunting may be sudden and catastrophic. A minority of individuals with HHT have GI bleeding, which is rarely seen before age 50 years.</Attribute>
                <XRef ID="NBK1351" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">SMAD4-Related Hereditary Hemorrhagic Telangiectasia</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301525</ID>
                <ID Source="BookShelf">NBK1351</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301642</ID>
                <ID Source="BookShelf">NBK1469</ID>
              </Citation>
              <Citation Type="general" Abbrev="HHT Foundation Int'l, 2011">
                <ID Source="PubMed">19553198</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Shovlin et al., 2000">
                <ID Source="PubMed">10751092</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="HHT Foundation Int'l, 2020">
                <ID Source="PubMed">32894695</ID>
              </Citation>
              <XRef ID="2929" DB="Orphanet" />
              <XRef ID="C1832942" DB="MedGen" />
              <XRef ID="MONDO:0008278" DB="MONDO" />
              <XRef Type="MIM" ID="175050" DB="OMIM" />
            </Trait>
            <Trait ID="5725" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Exocrine pancreatic carcinoma</ElementValue>
                <XRef ID="MONDO:0005192" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PANCREATIC ACINAR CARCINOMA</ElementValue>
                <XRef Type="MIM" ID="260350" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PANCREATIC CARCINOMA</ElementValue>
                <XRef Type="MIM" ID="260350" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pancreatic cancer, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pancreatic carcinoma, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Carcinoma of pancreas</ElementValue>
                <XRef ID="372142002" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000593405" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569885" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512726" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000012368" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520869" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520872" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592353" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530120" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520069" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000523334" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000593406" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520871" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520865" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000523331" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525919" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569881" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592354" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000514885" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000523332" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528055" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520866" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552440" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520870" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520868" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520394" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000597429" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520867" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509790" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000593404" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="AHRQ, 2013">
                <URL>https://www.cms.gov/Medicare/Coverage/DeterminationProcess/downloads/id90TA.pdf</URL>
                <CitationText>Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin (ARCHIVED)</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2006">
                <ID Source="PubMed">17060676</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2014">
                <ID Source="PubMed">24493721</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="1333" DB="Orphanet" />
              <XRef ID="217074" DB="Orphanet" />
              <XRef ID="C0235974" DB="MedGen" />
              <XRef ID="C562463" DB="MeSH" />
              <XRef ID="MONDO:0005192" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2354" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2502" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">JP/HHT SYNDROME</ElementValue>
                <XRef Type="MIM" ID="175050" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">JUVENILE POLYPOSIS WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA</ElementValue>
                <XRef Type="MIM" ID="175050" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">POLYPOSIS, GENERALIZED JUVENILE, WITH PULMONARY ARTERIOVENOUS MALFORMATION</ElementValue>
                <XRef Type="MIM" ID="175050" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">TELANGIECTASIA, HEREDITARY HEMORRHAGIC, WITH JUVENILE POLYPOSIS COLI</ElementValue>
                <XRef Type="MIM" ID="175050" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome</ElementValue>
                <XRef ID="Juvenile+polyposis-hereditary+hemorrhagic+telangiectasia+syndrome/8700" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008278" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">JPHT</ElementValue>
                <XRef Type="MIM" ID="175050" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">JPS/HHT</ElementValue>
                <XRef Type="MIM" ID="175050" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">JP/HHT</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hereditary hemorrhagic telangiectasia (HHT) is characterized by the presence of multiple arteriovenous malformations (AVMs) that lack intervening capillaries and result in direct connections between arteries and veins. The most common clinical manifestation is spontaneous and recurrent nosebleeds (epistaxis) beginning on average at age 12 years. Telangiectases (small AVMs) are characteristically found on the lips, tongue, buccal and gastrointestinal (GI) mucosa, face, and fingers. The appearance of telangiectases is generally later than epistaxis but may be during childhood. Large AVMs occur most often in the lungs, liver, or brain; complications from bleeding or shunting may be sudden and catastrophic. A minority of individuals with HHT have GI bleeding, which is rarely seen before age 50 years.</Attribute>
                <XRef ID="NBK1351" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">SMAD4-Related Hereditary Hemorrhagic Telangiectasia</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301525</ID>
                <ID Source="BookShelf">NBK1351</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301642</ID>
                <ID Source="BookShelf">NBK1469</ID>
              </Citation>
              <Citation Type="general" Abbrev="HHT Foundation Int'l, 2011">
                <ID Source="PubMed">19553198</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Shovlin et al., 2000">
                <ID Source="PubMed">10751092</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="HHT Foundation Int'l, 2020">
                <ID Source="PubMed">32894695</ID>
              </Citation>
              <XRef ID="2929" DB="Orphanet" />
              <XRef ID="C1832942" DB="MedGen" />
              <XRef ID="MONDO:0008278" DB="MONDO" />
              <XRef Type="MIM" ID="175050" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="74620" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2251" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Growth mental deficiency syndrome of Myhre</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Myhre syndrome</ElementValue>
                <XRef ID="Growth+Mental+Deficiency+Syndrome+of+Myhre/3195" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007688" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LARYNGOTRACHEAL STENOSIS, ARTHROPATHY, PROGNATHISM, AND SHORT STATURE</ElementValue>
                <XRef Type="MIM" ID="139210" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LAPS SYNDROME</ElementValue>
                <XRef Type="MIM" ID="139210" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MYHRS</ElementValue>
                <XRef Type="MIM" ID="139210" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Myhre syndrome is a connective tissue disorder with multisystem involvement, progressive and proliferative fibrosis that may occur spontaneously or following trauma or surgery, mild-to-moderate intellectual disability, and in some instances, autistic-like behaviors. Organ systems primarily involved include: cardiovascular (congenital heart defects, long- and short-segment stenosis of the aorta and peripheral arteries, pericardial effusion, constrictive pericarditis, restrictive cardiomyopathy, and hypertension); respiratory (choanal stenosis, laryngotracheal narrowing, obstructive airway disease, or restrictive pulmonary disease), gastrointestinal (pyloric stenosis, duodenal strictures, severe constipation); and skin (thickened particularly on the hands and extensor surfaces). Additional findings include distinctive craniofacial features and skeletal involvement (intrauterine growth restriction, short stature, limited joint range of motion). To date, 55 individuals with molecularly confirmed Myhre syndrome have been reported.</Attribute>
                <XRef ID="NBK425723" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2572" />
                <XRef ID="2572" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">28406602</ID>
                <ID Source="BookShelf">NBK425723</ID>
              </Citation>
              <XRef ID="2588" DB="Orphanet" />
              <XRef ID="C0796081" DB="MedGen" />
              <XRef ID="MONDO:0007688" DB="MONDO" />
              <XRef Type="MIM" ID="139210" DB="OMIM" />
            </Trait>
            <Trait ID="2502" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">JP/HHT SYNDROME</ElementValue>
                <XRef Type="MIM" ID="175050" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">JUVENILE POLYPOSIS WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA</ElementValue>
                <XRef Type="MIM" ID="175050" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">POLYPOSIS, GENERALIZED JUVENILE, WITH PULMONARY ARTERIOVENOUS MALFORMATION</ElementValue>
                <XRef Type="MIM" ID="175050" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">TELANGIECTASIA, HEREDITARY HEMORRHAGIC, WITH JUVENILE POLYPOSIS COLI</ElementValue>
                <XRef Type="MIM" ID="175050" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome</ElementValue>
                <XRef ID="Juvenile+polyposis-hereditary+hemorrhagic+telangiectasia+syndrome/8700" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008278" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">JPHT</ElementValue>
                <XRef Type="MIM" ID="175050" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">JPS/HHT</ElementValue>
                <XRef Type="MIM" ID="175050" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">JP/HHT</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hereditary hemorrhagic telangiectasia (HHT) is characterized by the presence of multiple arteriovenous malformations (AVMs) that lack intervening capillaries and result in direct connections between arteries and veins. The most common clinical manifestation is spontaneous and recurrent nosebleeds (epistaxis) beginning on average at age 12 years. Telangiectases (small AVMs) are characteristically found on the lips, tongue, buccal and gastrointestinal (GI) mucosa, face, and fingers. The appearance of telangiectases is generally later than epistaxis but may be during childhood. Large AVMs occur most often in the lungs, liver, or brain; complications from bleeding or shunting may be sudden and catastrophic. A minority of individuals with HHT have GI bleeding, which is rarely seen before age 50 years.</Attribute>
                <XRef ID="NBK1351" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">SMAD4-Related Hereditary Hemorrhagic Telangiectasia</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301525</ID>
                <ID Source="BookShelf">NBK1351</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301642</ID>
                <ID Source="BookShelf">NBK1469</ID>
              </Citation>
              <Citation Type="general" Abbrev="HHT Foundation Int'l, 2011">
                <ID Source="PubMed">19553198</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Shovlin et al., 2000">
                <ID Source="PubMed">10751092</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="HHT Foundation Int'l, 2020">
                <ID Source="PubMed">32894695</ID>
              </Citation>
              <XRef ID="2929" DB="Orphanet" />
              <XRef ID="C1832942" DB="MedGen" />
              <XRef ID="MONDO:0008278" DB="MONDO" />
              <XRef Type="MIM" ID="175050" DB="OMIM" />
            </Trait>
            <Trait ID="5725" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Exocrine pancreatic carcinoma</ElementValue>
                <XRef ID="MONDO:0005192" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PANCREATIC ACINAR CARCINOMA</ElementValue>
                <XRef Type="MIM" ID="260350" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PANCREATIC CARCINOMA</ElementValue>
                <XRef Type="MIM" ID="260350" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pancreatic cancer, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pancreatic carcinoma, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Carcinoma of pancreas</ElementValue>
                <XRef ID="372142002" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000593405" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569885" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512726" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000012368" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520869" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520872" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592353" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530120" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520069" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000523334" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000593406" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520871" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520865" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000523331" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525919" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569881" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592354" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000514885" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000523332" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528055" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520866" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552440" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520870" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520868" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520394" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000597429" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520867" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509790" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000593404" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="AHRQ, 2013">
                <URL>https://www.cms.gov/Medicare/Coverage/DeterminationProcess/downloads/id90TA.pdf</URL>
                <CitationText>Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin (ARCHIVED)</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2006">
                <ID Source="PubMed">17060676</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2014">
                <ID Source="PubMed">24493721</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="1333" DB="Orphanet" />
              <XRef ID="217074" DB="Orphanet" />
              <XRef ID="C0235974" DB="MedGen" />
              <XRef ID="C562463" DB="MeSH" />
              <XRef ID="MONDO:0005192" DB="MONDO" />
            </Trait>
            <Trait ID="55407" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Juvenile polyposis syndrome</ElementValue>
                <XRef ID="Juvenile+polyposis+syndrome/3939" DB="Genetic Alliance" />
                <XRef ID="MONDO:0017380" DB="MONDO" />
                <XRef ID="9273005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polyposis juvenile intestinal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polyposis familial of entire gastrointestinal tract</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PJI</ElementValue>
                <XRef Type="MIM" ID="174900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">JIP</ElementValue>
                <XRef Type="MIM" ID="174900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">JPS</ElementValue>
                <XRef Type="MIM" ID="174900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Juvenile polyposis syndrome (JPS) is characterized by predisposition to hamartomatous polyps in the gastrointestinal (GI) tract, specifically in the stomach, small intestine, colon, and rectum. The term "juvenile" refers to the type of polyp rather than to the age of onset of polyps. Most individuals with JPS have some polyps by age 20 years; some may have only four or five polyps over their lifetime, whereas others in the same family may have more than 100. If the polyps are left untreated, they may cause bleeding and anemia. Most juvenile polyps are benign; however, malignant transformation can occur. Risk for GI cancers ranges from 11% to 86%. Most of this increased risk is attributed to colon cancer, but cancers of the stomach, upper GI tract, and pancreas have also been reported. A combined syndrome of JPS and hereditary hemorrhagic telangiectasia (HHT) is present in most individuals with an SMAD4 pathogenic variant.</Attribute>
                <XRef ID="NBK1469" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3065" />
                <XRef ID="3065" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301642</ID>
                <ID Source="BookShelf">NBK1469</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Genetics of Colorectal Cancer">
                <ID Source="PubMed">26389505</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="2929" DB="Orphanet" />
              <XRef ID="C0345893" DB="MedGen" />
              <XRef ID="MONDO:0017380" DB="MONDO" />
              <XRef Type="MIM" ID="174900" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="65684" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="55407" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Juvenile polyposis syndrome</ElementValue>
                <XRef ID="Juvenile+polyposis+syndrome/3939" DB="Genetic Alliance" />
                <XRef ID="MONDO:0017380" DB="MONDO" />
                <XRef ID="9273005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polyposis juvenile intestinal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polyposis familial of entire gastrointestinal tract</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PJI</ElementValue>
                <XRef Type="MIM" ID="174900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">JIP</ElementValue>
                <XRef Type="MIM" ID="174900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">JPS</ElementValue>
                <XRef Type="MIM" ID="174900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Juvenile polyposis syndrome (JPS) is characterized by predisposition to hamartomatous polyps in the gastrointestinal (GI) tract, specifically in the stomach, small intestine, colon, and rectum. The term "juvenile" refers to the type of polyp rather than to the age of onset of polyps. Most individuals with JPS have some polyps by age 20 years; some may have only four or five polyps over their lifetime, whereas others in the same family may have more than 100. If the polyps are left untreated, they may cause bleeding and anemia. Most juvenile polyps are benign; however, malignant transformation can occur. Risk for GI cancers ranges from 11% to 86%. Most of this increased risk is attributed to colon cancer, but cancers of the stomach, upper GI tract, and pancreas have also been reported. A combined syndrome of JPS and hereditary hemorrhagic telangiectasia (HHT) is present in most individuals with an SMAD4 pathogenic variant.</Attribute>
                <XRef ID="NBK1469" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3065" />
                <XRef ID="3065" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301642</ID>
                <ID Source="BookShelf">NBK1469</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Genetics of Colorectal Cancer">
                <ID Source="PubMed">26389505</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="2929" DB="Orphanet" />
              <XRef ID="C0345893" DB="MedGen" />
              <XRef ID="MONDO:0017380" DB="MONDO" />
              <XRef Type="MIM" ID="174900" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="81098" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
            <Trait ID="16634" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Familial thoracic aortic aneurysm and aortic dissection</ElementValue>
                <XRef ID="MONDO:0019625" DB="MONDO" />
                <XRef ID="91387" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thoracic aortic aneurysms and dissections</ElementValue>
                <XRef ID="UWMG_7008129" DB="CSER _CC_NCGL, University of Washington" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thoracic aortic aneurysm and aortic dissection</ElementValue>
                <XRef ID="Thoracic+Aortic+Aneurysms+and+Aortic+Dissections/9386" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EDS</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">TAAD</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2249" />
                <XRef ID="2249" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301299</ID>
                <ID Source="BookShelf">NBK1120</ID>
              </Citation>
              <Citation Type="general" Abbrev="CCS, 2014">
                <ID Source="PubMed">24882528</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESC, 2014">
                <ID Source="PubMed">25173340</ID>
              </Citation>
              <XRef ID="91387" DB="Orphanet" />
              <XRef ID="C4707243" DB="MedGen" />
              <XRef ID="MONDO:0019625" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS607086" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1735" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="10229" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Colonic carcinoma</ElementValue>
                <XRef ID="MONDO:0002032" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Colon carcinoma</ElementValue>
                <XRef ID="MONDO:0002032" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Carcinoma of colon</ElementValue>
                <XRef ID="269533000" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CRC</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Lynch syndrome is characterized by an increased risk for colorectal cancer (CRC) and cancers of the endometrium, ovary, stomach, small bowel, urinary tract, biliary tract, brain (usually glioblastoma), skin (sebaceous adenomas, sebaceous carcinomas, and keratoacanthomas), pancreas, and prostate. Cancer risks and age of onset vary depending on the associated gene. Several other cancer types have been reported to occur in individuals with Lynch syndrome (e.g., breast, sarcomas, adrenocortical carcinoma). However, the data are not sufficient to demonstrate that the risk of developing these cancers is increased in individuals with Lynch syndrome.</Attribute>
                <XRef ID="NBK1211" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301390</ID>
                <ID Source="BookShelf">NBK1211</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGAPP, 2009">
                <ID Source="pmc">2743612</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGAPP, 2009">
                <ID Source="pmc">2743610</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="AMA/NCHPEG, 2012">
                <URL>http://www.nchpeg.org/documents/crc/11-0456%20Fact%20sheets%20(MSI%20and%20IHC%20testing).pdf</URL>
              </Citation>
              <Citation Type="general" Abbrev="NACB, 2008">
                <ID Source="PubMed">19042984</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="AHRQ, 2013">
                <URL>https://www.cms.gov/Medicare/Coverage/DeterminationProcess/downloads/id90TA.pdf</URL>
                <CitationText>Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin (ARCHIVED)</CitationText>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Imperiale et al., 2014">
                <ID Source="PubMed">25006736</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2006">
                <ID Source="PubMed">17060676</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="NCCN, 2011">
                <ID Source="PubMed">22138009</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACP MPDG, 2014">
                <ID Source="PubMed">24996433</ID>
              </Citation>
              <Citation Type="general" Abbrev="SEAP/SEOM, 2012">
                <ID Source="PubMed">22855150</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESMO, 2012">
                <ID Source="PubMed">23012255</ID>
              </Citation>
              <Citation Type="general" Abbrev="SEAP/SEOM, 2015">
                <ID Source="PubMed">25373533</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGTM, 2014">
                <ID Source="PubMed">23852704</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGAPP, 2013">
                <ID Source="PubMed">23429431</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Colon Cancer, 2024</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="EHTG/ESCP, 2021">
                <ID Source="PubMed">34043773</ID>
              </Citation>
              <Citation Type="general" Abbrev="SEAP/SEOM, 2020">
                <ID Source="PubMed">32418154</ID>
                <ID Source="pmc">7505870</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Colon-Cancer.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Family History ACT Sheet, Colon Cancer (Asymptomatic), 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2021">
                <URL>https://www.nice.org.uk/guidance/ng151</URL>
                <CitationText>UK NICE Guideline NG151, Colorectal cancer, 2021</CitationText>
              </Citation>
              <XRef ID="C0699790" DB="MedGen" />
              <XRef ID="MONDO:0002032" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2255" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2501" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Juvenile polyposis coli</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Generalized juvenile polyposis/juvenile polyposis coli</ElementValue>
                <XRef ID="MONDO:0008276" DB="MONDO" />
                <XRef ID="329971" DB="Orphanet" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Juvenile polyposis syndrome (JPS) is characterized by predisposition to hamartomatous polyps in the gastrointestinal (GI) tract, specifically in the stomach, small intestine, colon, and rectum. The term "juvenile" refers to the type of polyp rather than to the age of onset of polyps. Most individuals with JPS have some polyps by age 20 years; some may have only four or five polyps over their lifetime, whereas others in the same family may have more than 100. If the polyps are left untreated, they may cause bleeding and anemia. Most juvenile polyps are benign; however, malignant transformation can occur. Risk for GI cancers ranges from 11% to 86%. Most of this increased risk is attributed to colon cancer, but cancers of the stomach, upper GI tract, and pancreas have also been reported. A combined syndrome of JPS and hereditary hemorrhagic telangiectasia (HHT) is present in most individuals with an SMAD4 pathogenic variant.</Attribute>
                <XRef ID="NBK1469" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17508" />
                <XRef ID="17508" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301642</ID>
                <ID Source="BookShelf">NBK1469</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2004">
                <ID Source="PubMed">15604628</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACG, 2015">
                <ID Source="PubMed">25645574</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Genetics of Colorectal Cancer">
                <ID Source="PubMed">26389505</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <XRef ID="329971" DB="Orphanet" />
              <XRef ID="C1868081" DB="MedGen" />
              <XRef ID="MONDO:0008276" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1894779" SubmissionDate="2019-03-21" DateLastUpdated="2019-08-26" DateCreated="2019-08-26">
        <ClinVarSubmissionID localKey="89848522|Orphanet:ORPHA2929" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000966985" DateUpdated="2019-08-26" DateCreated="2019-08-26" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-07-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18823382</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22316667</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23399955</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22748914</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26681312</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23239472</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27375208</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28944238</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16152648</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9582123</ID>
          </Citation>
          <Comment>The p.Asp415GlufsX20 variant in SMAD4 has been reported in &gt;20 probands (2 de no vo occurrences) with juvenile polyposis syndrome (JPS) and segregated with disea se in &gt;20 relatives of multiple families (Howe 1998, Handra-Luca 2005, Calva-Cer queira 2009, Piepoli 2012, Ngeow 2013, Teekakirikul 2013, AlBalwi 2015, Susswein 2015, Burmester 2016, DeRycke 2017). This variant was absent from large populat ion databases but has been reported in ClinVar (Variation ID: 142253). This vari ant is predicted to cause a frameshift, which alters the protein?s amino acid se quence beginning at position 415 and leads to a premature termination codon 20 a mino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Heterozygous loss of function of the SMAD4 gene is an establi shed disease mechanism in JPS. In addition, in vitro functional studies provide some evidence that the p.Asp415GlufsX20 variant may impact protein function (Car r 2012). In summary, this variant meets criteria to be classified as pathogenic for JPS in an autosomal dominant manner based upon prevalence in probands, segre gation studies, absence from controls, functional evidence, and the predicted im pact on protein. ACMG/AMP Criteria applied: PVS1, PS4, PM6_Strong, PP1_Strong, P M2.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMAD4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_005359.5:EXON 10</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_005359.5:c.1245_1248delCAGA</Name>
            <Name>p.Asp415GlufsX20</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000018.9:g.48593494_48593497delCAGA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Juvenile polyposis syndrome</ElementValue>
            </Name>
            <XRef DB="Orphanet" ID="ORPHA2929" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5348959</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4022229" SubmissionDate="2022-01-07" DateLastUpdated="2022-01-08" DateCreated="2022-01-08">
        <ClinVarSubmissionID localKey="Db4KrQBSZeoE7-orUyypkfw6T_QKbijhMVgvuqtrfX0|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002052812" DateUpdated="2022-01-08" DateCreated="2022-01-08" Type="SCV" Version="1" SubmitterName="Color Diagnostics, LLC DBA Color Health" OrgID="505849" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-01-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant deletes 4 nucleotides in exon 10 of the SMAD4 gene, creating a frameshift and premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in individuals affected with juvenile polyposis syndrome (PMID: 9582123, 15235019, 16152648, 17873119, 18823382, 22748914, 23239472, 23399955) along with individuals affected with atypical forms of gastrointestinal polyposis (PMID: 18355998, 22748914, 23239472). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Loss of SMAD4 function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>NGS</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMAD4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005359.5:c.1245_1248del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10906337</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="377366" SubmissionDate="2022-08-31" DateLastUpdated="2023-03-04" DateCreated="2015-02-24">
        <ClinVarSubmissionID localKey="GDXSV:237920" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000211665" DateUpdated="2023-03-04" DateCreated="2015-02-24" Type="SCV" Version="12" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Published functional studies demonstrate a damaging effect: decreased BMP-mediated transcriptional activity (Carr et al., 2012); Observed in individuals with a personal or family history consistent with pathogenic variants in this gene referred for testing at GeneDx and in the published literature (Aretz et al.,2007; Calva-Cerqueira et al., 2009; Gallione et al., 2010; Ngeow et al., 2013; Teekakirikul et al., 2013; Bruceta et al., 2018; Inoguchi et al., 2019); Segregates with disease in many affected individuals from several families referred for genetic testing at GeneDx and in published literature (Howe et al., 1998; Piepoli et al., 2012; Burmester et al., 2016); Not observed at significant frequency in large population cohorts (gnomAD); Also known as 1244_1247delACAG, 1372_1375del4, and 1242_45delAGAC; This variant is associated with the following publications: (PMID: 15235019, 24506336, 16152648, 26681312, 20101697, 18355998, 25931195, 23239472, 9582123, 22748914, 23399955, 17873119, 18823382, 27375208, 28526081, 28944238, 28152038, 30210120, 29634562, 31447099, 33097490, 30787465, 27535533, 22316667, 26171675)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMAD4" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:58670</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005359.5:c.1245_1248del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_126_20220831054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_92_20220302054205</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1349331" SubmissionDate="2017-10-31" DateLastUpdated="2018-02-19" DateCreated="2018-02-19">
        <ClinVarSubmissionID localKey="NM_005359.5:c.1245_1248del|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000692037" DateUpdated="2018-02-19" DateCreated="2018-02-19" Type="SCV" Version="1" SubmitterName="Mayo Clinic Laboratories, Mayo Clinic" OrgID="500068" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMAD4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.Asp415Glufs*20</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005359.5:c.1245_1248del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB3178674</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2645470" SubmissionDate="2020-04-29" DateLastUpdated="2020-06-18" DateCreated="2020-06-18">
        <ClinVarSubmissionID localKey="NM_005359.5:c.1245_1248delCAGA|MedGen:C0345893" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001338144" DateUpdated="2020-06-18" DateCreated="2020-06-18" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-02-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22316667</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9582123</ID>
          </Citation>
          <Comment>Variant summary: SMAD4 c.1245_1248delCAGA (p.Asp415GlufsX20) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 251950 control chromosomes (gnomAD and publication). c.1245_1248delCAGA has been reported in the literature in multiple individuals affected with Juvenile Polyposis Syndrome and was also shown to segregate with the disease (Carr_2012, Howe_1998). These data indicate that the variant is very likely to be associated with disease. Experimental evidence evaluating an impact on protein function demonstrated the variant leads to decreased bone morphogenetic protein signaling (Carr_2012). Six ClinVar submitters (evaluation after 2014) cite the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMAD4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005359.5:c.1245_1248delCAGA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Juvenile polyposis syndrome</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0345893" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7346674</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2820202" SubmissionDate="2020-04-20" DateLastUpdated="2020-08-15" DateCreated="2020-08-15">
        <ClinVarSubmissionID localKey="CV_526|OMIM:174900" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001429036" DateUpdated="2020-08-15" DateCreated="2020-08-15" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics, University of Leipzig Medical Center" OrgID="506086" OrganizationCategory="clinic" OrgAbbreviation="UKL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-11-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMAD4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005359.5:c.1245_1248del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="174900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7303396</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3054007" SubmissionDate="2021-03-31" DateLastUpdated="2021-04-13" DateCreated="2021-04-13">
        <ClinVarSubmissionID localKey="chr18:48593489-48593494:dd6c5880df2cc1b6575b62b17ab64b03-COLON" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001552894" DateUpdated="2021-04-13" DateCreated="2021-04-13" Type="SCV" Version="1" SubmitterName="Department of Pathology and Laboratory Medicine, Sinai Health System" OrgID="506152" OrganizationCategory="laboratory" OrgAbbreviation="PLM-SHS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506759" SubmitterName="Franklin by Genoox" Type="secondary" OrganizationCategory="other" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The SMAD4 p.Asp415Glufs*20 variant was identified in 21 of 1596 proband chromosomes (frequency: 0.01) from individuals or families with juvenile and moderate-load polyposis and was not identified in 484 control chromosomes from healthy individuals (Howe 1998, Aretz 2007, Calva-Cerqueira 2009, Pinitiliciuc 2008, Piepoli 2012, Ngeow 2013, Burmester 2016). The variant was identified in dbSNP (rs80338965) as â€šÃ„Ãºwith pathogenic allele, ClinVar (classified as pathogenic by Invitae, GeneDx, Ambry Genetics and 6 other submitters) and LOVD 3.0 (observed 76x). The variant was not identified in the following control databases: the Exome Aggregation Consortium (August 8th 2016) or the Genome Aggregation Database (Feb 27, 2017). In HEK-293T cells, expression of the variant decreased bone morphogenetic protein signaling (Carr 2012). The c.1245_1248del variant is predicted to cause a frameshift, which alters the protein's amino acid sequence beginning at codon 415 and leads to a premature stop codon at position 434. This alteration is then predicted to result in a truncated or absent protein and loss of function. Loss of function variants of the SMAD4 gene are an established mechanism of disease in juvenile polyposis syndrome and is the type of variant expected to cause the disorder. In summary, based on the above information, this variant meets our laboratoryâ€šÃ„Ã´s criteria to be classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMAD4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="18" alternateAllele="T" referenceAllele="TAGAC" start="48593490" stop="48593494" variantLength="5" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0002032" />
          </Trait>
        </TraitSet>
        <StudyName>The Canadian Open Genetics Repository (COGR)</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB9371647</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="41150" SubmissionDate="2013-01-08" DateLastUpdated="2022-10-01" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="NM_005359.5:c.1244_1247delACAG_NBK1469" title="NM_005359.5:c.1244_1247delACAG and Juvenile Polyposis Syndrome" />
        <ClinVarAccession Accession="SCV000041150" DateUpdated="2022-10-01" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">15235019</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">20301642</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="BookShelf">NBK1469</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <Purpose>Assert pathogenicity</Purpose>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="80338965" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005359.5:c.1244_1247delACAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1868081" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7525527" SubmissionDate="2023-07-27" DateLastUpdated="2024-02-04" DateCreated="2024-02-04">
        <ClinVarSubmissionID localKey="NM_005359.6:c.1245_1248del|OMIM:175050" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004022162" DateUpdated="2024-02-04" DateCreated="2024-02-04" Type="SCV" Version="1" SubmitterName="deCODE genetics, Amgen" OrgID="506996" OrganizationCategory="laboratory" OrgAbbreviation="DCGN" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-21">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The variant NM_005359.6:c.1245_1248del (chr18:51067120) in SMAD4 was detected in 2 heterozygotes out of 58K WGS Icelanders (MAF= 0,002%). This variant has been reported in ClinVar previously as pathogenic. Based on ACMG criteria (PVS1, PM2) this variant classifies as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Icelandic</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMAD4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005359.6:c.1245_1248del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="175050" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13712926</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1739729" SubmissionDate="2023-12-22" DateLastUpdated="2024-01-06" DateCreated="2018-02-19">
        <ClinVarSubmissionID localKey="S1733|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000889841" DateUpdated="2024-01-06" DateCreated="2018-02-19" Type="SCV" Version="3" SubmitterName="Quest Diagnostics Nichols Institute San Juan Capistrano" OrgID="500110" OrganizationCategory="laboratory" OrgAbbreviation="Quest Diagnostics" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17873119</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23399955</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18355998</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23239472</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27375208</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22316667</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10398437</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33097490</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">35943490</ID>
          </Citation>
          <Comment>This variant alters the translational reading frame of the SMAD4 mRNA and causes the premature termination of SMAD4 protein synthesis. In the published literature, this variant has been reported in multiple individuals with juvenile polyposis syndrome (JPS) (PMID: 33097490 (2021), 27375208 (2016), 23239472 (2013), 18355998 (2008), 17873119 (2007), 10398437 (1999), 9582123 (1998)). In a functional study, the variant reduced downstream bone morphogenic protein signaling in vitro (PMID: 22316667 (2012)). This variant has not been reported in large, multi-ethnic general populations (Genome Aggregation Database, http://gnomad.broadinstitute.org). Based on the available information, this variant is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Quest Diagnostics criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005359.5:c.1245_1248del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14108248</SubmissionName>
          <SubmissionName>SUB4481696</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="484898" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2016-01-31">
        <ClinVarSubmissionID localKey="591353|MedGen:C0345893" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000259936" DateUpdated="2024-02-20" DateCreated="2016-01-31" Type="SCV" Version="11" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16152648</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16436638</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22810475</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9582123</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17873119</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18355998</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23239472</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23399955</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27375208</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Asp415Glufs*20) in the SMAD4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SMAD4 are known to be pathogenic (PMID: 16152648, 16436638, 22810475). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with juvenile polyposis syndrome (JPS) (PMID: 9582123, 17873119, 18355998, 23239472, 23399955, 27375208). It has also been observed to segregate with disease in related individuals. This variant is also known as 1244_7delACAG and as a 4-bp deletion between nucleotides 1372 and 1375. ClinVar contains an entry for this variant (Variation ID: 142253). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMAD4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000018.9:g.48593491_48593494del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0345893" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9143239" SubmissionDate="2024-04-22" DateLastUpdated="2024-05-01" DateCreated="2024-05-01">
        <ClinVarSubmissionID localKey="100096998|OMIM:175050" />
        <ClinVarAccession Accession="SCV004932867" DateUpdated="2024-05-01" DateCreated="2024-05-01" Type="SCV" Version="1" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/8ufcwsf2/myriad_genetics_classification_criteria_2023.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMAD4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="18" alternateAllele="A" referenceAllele="ACAGA" start="48593493" stop="48593497" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">100096998</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="175050" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14395420</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="304747" SubmissionDate="2024-05-11" DateLastUpdated="2024-06-09" DateCreated="2014-08-06">
        <ClinVarSubmissionID localKey="a8298|MedGen:C0027672;C4707243" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000186232" DateUpdated="2024-06-09" DateCreated="2014-08-06" Type="SCV" Version="8" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.1245_1248delCAGA pathogenic mutation, located in coding exon 9 of the SMAD4 gene, results from a deletion of four nucleotides between positions 1245 and 1248, causing a translational frameshift with a predicted alternate stop codon (p.D415Efs*20). This mutation has been reported in multiple individuals diagnosed with juvenile polyposis syndrome (JPS) (Aretz S et al. J. Med. Genet. 2007 Nov;44:702-9; Howe JR et al. Science. 1998 May;280:1086-8; Burmester JK et al. Dig Liver Dis. 2016 Oct;48:1255-9), multiple individuals with mixed polyposis, 4 of 5 whom had predominately juvenile polyps (Ngeow J et al. Gastroenterology. 2013 Jun;144:1402-9, 1409.e1-5), and in individuals diagnosed with JPS-hereditary hemorrhagic telangiectasia (JPS-HHT) (Teekakirikul P et al. Am. J. Med. Genet. A. 2013 Jan;161A:185-91; Heald B et al. Am. J. Med. Genet. A. 2015 Aug;167A:1758-62). A functional study showed this mutation leads to a 33% reduction in luciferase activity compared to wild-type, indicating that the mutation negatively impacted downstream bone morphogenetic protein (BMP) pathway signaling (Carr JC et al. J. Surg. Res. 2012 May;174:211-4). Of note, this alteration is also designated as 1244_7delACAG or 1372_1375del4 in published literature. In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMAD4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005359.5:c.1245_1248delCAGA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4707243" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_error_correct_1a</SubmissionName>
          <SubmissionName>NonExomeUpdate_081220AmbryReport</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="29283" SubmissionDate="2017-11-20" DateLastUpdated="2017-11-23" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="600993.0005_JUVENILE POLYPOSIS SYNDROME" title="SMAD4, 4-BP DEL, NT1372_JUVENILE POLYPOSIS SYNDROME" />
        <ClinVarAccession Accession="SCV000029283" DateUpdated="2017-11-23" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2002-05-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 3 unrelated cases of familial juvenile polyposis (JPS; 174900), Howe et al. (1998) identified a 4-bp deletion involving codons 414 to 416 in exon 9 of the MADH4 gene and resulting in a frameshift with a premature stop at codon 434.</Attribute>
              <Citation>
                <ID Source="PubMed">9582123</ID>
              </Citation>
              <XRef DB="OMIM" ID="174900" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Friedl et al. (1999) examined 11 unrelated patients with juvenile polyposis for MADH4 germline mutations by direct sequencing of genomic DNA encompassing all 11 exons of the gene. They observed a 4-bp deletion of nucleotides 1372-1375, ACAG, in exon 9 in 2 unrelated patients. Examination with microsatellite markers flanking MADH4 supported an independent origin of the mutation in these 2 families. Combined with previous data (Howe et al., 1998), the results of Friedl et al. (1999) indicated that the 4-bp deletion accounts for about one-fourth of all juvenile polyposis cases and that other MADH4 mutations occur in an additional 15% of patients.</Attribute>
              <Citation>
                <ID Source="PubMed">10398437</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">9582123</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Howe et al. (2002) did a haplotype analysis on 4 families with juvenile polyposis that had been described as having the same SMAD4 deletion (1244-1247delAGAC). The families came from Iowa, Mississippi, Texas, and Finland. No common haplotype was observed in these families. A 14-bp region containing the deletion had 4 direct repeats and 1 inverted repeat. Because no common ancestor was suggested by haplotype analysis and the sequence flanking the deletion contains repeats frequently associated with microdeletions, this common SMAD4 deletion most probably represents a mutation hotspot.</Attribute>
              <Citation>
                <ID Source="PubMed">11920286</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMAD4" />
          </GeneList>
          <Name>SMAD4, 4-BP DEL, NT1372</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DEL, NT1372</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="600993.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">JUVENILE POLYPOSIS SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1762566" SubmissionDate="2018-12-12" DateLastUpdated="2019-04-25" DateCreated="2019-04-25">
        <ClinVarSubmissionID localKey="525|OMIM:175050;139210;260350;174900" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000898987" DateUpdated="2019-04-25" DateCreated="2019-04-25" Type="SCV" Version="1" SubmitterName="Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago" OrgID="506344" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-09-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>SMAD4 NM_005359.5 exon 10 p.Asp415Glufs*20 (c.1245_1248delCAGA): This variant has been reported in the literature (alternate nomenclature: c.1244_1247del, c.1242_1245delAGAC, c.1372_1375del4) in multiple individuals with juvenile polyposis syndrome (JPS) (Howe 1998 PMID:9582123, Aretz 2007 PMID:17873119, Pintiliciuc 2008 PMID:18355998, Calva-Cerqueira 2009 PMID:18823382, Piepoli 2012 PMID:22748914, Ngeow 2013 PMID:23399955, Blatter 2015 PMID:26171675, Burmester 2016 PMID:27375208) and was shown to segregate with disease in several affected family members (Howe 1998 PMID:9582123, Piepoli 2012 PMID:22748914, Burmester 2016 PMID:27375208). This variant was also identified in an individual presenting with JPS, hereditary hemorrhagic telangiectasia (HTT), and features of syndromic TAAD (Teekakirikul 2013 PMID:23239472). This variant is not present in large control databases, and it is present in ClinVar, with several labs classifying this variant as pathogenic (Variation ID:142253). Evolutionary conservation and computational predictive tools for this variant are limited or unavailable. However, an in vitro functional study showed significantly decreased luciferase activity with this deletion, which is suggested to have a negative impact on downstream BMP signaling (Carr 2012 PMID:22316667). However, these studies may not accurately represent in vivo biological function. This variant is a deletion of 4 nucleotides and creates a premature stop codon 20 amino acids downstream from this location which results in an absent or abnormal protein. Loss of function variants have been described as a mechanism of disease for this gene (Gallione 2010 PMID:20101697). In summary, this variant is classified as pathogenic based on the data above.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMAD4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="18" alternateAllele="-" referenceAllele="AGAC" start="48593491" stop="48593494" variantLength="4" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="175050" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="139210" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="260350" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="174900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4910108</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7336277" SubmissionDate="2023-05-02" DateLastUpdated="2023-05-20" DateCreated="2023-05-20">
        <ClinVarSubmissionID localKey="2864|OMIM:260350;139210;174900;175050" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV003924246" DateUpdated="2023-05-20" DateCreated="2023-05-20" Type="SCV" Version="1" SubmitterName="Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago" OrgID="506344" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-03-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>SMAD4 NM_005359.5 exon 10 p.Asp415Glufs*20 (c.1245_1248delCAGA): This variant has been reported in the literature (alternate nomenclature: c.1244_1247del, c.1242_1245delAGAC, c.1372_1375del4) in multiple individuals with juvenile polyposis syndrome (JPS) (Howe 1998 PMID:9582123, Aretz 2007 PMID:17873119, Pintiliciuc 2008 PMID:18355998, Calva-Cerqueira 2009 PMID:18823382, Piepoli 2012 PMID:22748914, Ngeow 2013 PMID:23399955, Blatter 2015 PMID:26171675, Burmester 2016 PMID:27375208) and was shown to segregate with disease in several affected family members (Howe 1998 PMID:9582123, Piepoli 2012 PMID:22748914, Burmester 2016 PMID:27375208). This variant was also identified in an individual presenting with JPS, hereditary hemorrhagic telangiectasia (HTT), and features of syndromic TAAD (Teekakirikul 2013 PMID:23239472). This variant is not present in large control databases, and it is present in ClinVar, with several labs classifying this variant as pathogenic (Variation ID:142253). Evolutionary conservation and computational predictive tools for this variant are limited or unavailable. However, an in vitro functional study showed significantly decreased luciferase activity with this deletion, which is suggested to have a negative impact on downstream BMP signaling (Carr 2012 PMID:22316667). However, these studies may not accurately represent in vivo biological function. This variant is a deletion of 4 nucleotides and creates a premature stop codon 20 amino acids downstream from this location which results in an absent or abnormal protein. Loss of function variants have been described as a mechanism of disease for this gene (Gallione 2010 PMID:20101697). In summary, this variant is classified as pathogenic based on the data above.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMAD4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh38" Chr="18" alternateAllele="T" referenceAllele="TAGAC" start="51067120" stop="51067124" variantLength="5" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="260350" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="139210" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="174900" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="175050" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13232579</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="29283" TraitType="Disease" MappingType="Name" MappingValue="JUVENILE POLYPOSIS SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0345893" Name="Juvenile polyposis syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="41150" TraitType="Disease" MappingType="XRef" MappingValue="C1868081" MappingRef="MedGen">
        <MedGen CUI="C1868081" Name="Generalized juvenile polyposis/juvenile polyposis coli" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1762566" TraitType="Disease" MappingType="XRef" MappingValue="174900" MappingRef="OMIM">
        <MedGen CUI="C0345893" Name="Juvenile polyposis syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7336277" TraitType="Disease" MappingType="XRef" MappingValue="139210" MappingRef="OMIM">
        <MedGen CUI="C0796081" Name="Myhre syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1349331" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1739729" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7525527" TraitType="Disease" MappingType="XRef" MappingValue="175050" MappingRef="OMIM">
        <MedGen CUI="C1832942" Name="Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1762566" TraitType="Disease" MappingType="XRef" MappingValue="260350" MappingRef="OMIM">
        <MedGen CUI="C2931038" Name="Familial pancreatic carcinoma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3054007" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0002032" MappingRef="MONDO">
        <MedGen CUI="C0699790" Name="Carcinoma of colon" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7336277" TraitType="Disease" MappingType="XRef" MappingValue="174900" MappingRef="OMIM">
        <MedGen CUI="C0345893" Name="Juvenile polyposis syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="377366" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="304747" TraitType="Disease" MappingType="XRef" MappingValue="C4707243" MappingRef="MedGen">
        <MedGen CUI="C4707243" Name="Familial thoracic aortic aneurysm and aortic dissection" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="484898" TraitType="Disease" MappingType="XRef" MappingValue="C0345893" MappingRef="MedGen">
        <MedGen CUI="C0345893" Name="Juvenile polyposis syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="304747" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4022229" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2820202" TraitType="Disease" MappingType="XRef" MappingValue="174900" MappingRef="OMIM">
        <MedGen CUI="C0345893" Name="Juvenile polyposis syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1762566" TraitType="Disease" MappingType="XRef" MappingValue="139210" MappingRef="OMIM">
        <MedGen CUI="C0796081" Name="Myhre syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9143239" TraitType="Disease" MappingType="XRef" MappingValue="175050" MappingRef="OMIM">
        <MedGen CUI="C1832942" Name="Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7336277" TraitType="Disease" MappingType="XRef" MappingValue="175050" MappingRef="OMIM">
        <MedGen CUI="C1832942" Name="Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1894779" TraitType="Disease" MappingType="Name" MappingValue="Juvenile polyposis syndrome" MappingRef="Preferred">
        <MedGen CUI="C0345893" Name="Juvenile polyposis syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7336277" TraitType="Disease" MappingType="XRef" MappingValue="260350" MappingRef="OMIM">
        <MedGen CUI="C2931038" Name="Familial pancreatic carcinoma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2645470" TraitType="Disease" MappingType="Name" MappingValue="Juvenile polyposis syndrome" MappingRef="Preferred">
        <MedGen CUI="C0345893" Name="Juvenile polyposis syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1762566" TraitType="Disease" MappingType="XRef" MappingValue="175050" MappingRef="OMIM">
        <MedGen CUI="C1832942" Name="Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2021-11-13">SCV000042393</Accession>
        <Description>not specified</Description>
      </SCV>
      <SCV>
        <Accession Version="1" DateDeleted="2021-11-13">SCV000042395</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

